Citi Reiterates Sell Rating on Hims and Hers (HIMS), Comments on Novo's Wegovy Price Promo: 'We see this as another potential headwind for HIMS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| (NYSE: HIMS) | Delayed: 27.53 -0.15 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.68 | 52 Week High | $ | |||
| Open | $27.97 | 52 Week Low | $ | |||
| Day High | $28.49 | P/E | N/A | |||
| Day Low | $27.38 | EPS | $ | |||
| Volume | 3,076,403 | |||||
| NOVARTIS AG (NYSE: NVS) | Delayed: 160.27 -0.52 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $160.79 | 52 Week High | $89.15 | |||
| Open | $160.54 | 52 Week Low | $69.84 | |||
| Day High | $161.44 | P/E | N/A | |||
| Day Low | $160.11 | EPS | $0.00 | |||
| Volume | 650,960 | |||||
